Inabata & Co.,Ltd. (8098.T) Bundle
Curious whether Inabata & Co., Ltd. (8098.T) is a quietly undervalued opportunity or a company with underlying strains? With net sales hitting ¥837.84 billion in FY ending March 31, 2025 - a 9.38% jump year-over-year and TTM revenue of ¥829.11 billion - the top line shows momentum, yet the picture is mixed: operating profit surged to ¥25.73 billion (+21.9%) while net income slipped slightly to ¥19.83 billion and free cash flow plunged 37.3% to ¥16.12 billion; balance-sheet metrics reveal total assets of ¥441.97 billion, a conservative debt-to-equity ratio of 0.51, cash and deposits of ¥66.19 billion (Sept. 30, 2025) and a market cap of ¥157.9 billion with P/E at 8.71 and P/S at 0.24 - factors that, together with ROE of 9.5%, dividend of ¥63.00 per share and EPS of ¥363.88, set the stage for a closer look at valuation, liquidity, risk from margins and FX, and growth levers like the Novacel consolidation, emerging-market expansion and R&D investments; read on to unpack the metrics that matter to investors.
Inabata & Co.,Ltd. (8098.T) - Revenue Analysis
Inabata & Co.,Ltd. reported net sales of ¥837.84 billion for the fiscal year ending March 31, 2025, a 9.38% increase versus the prior year. Revenue growth has been steady over recent years, with annual increases of 4.13% in FY2024 and 8.03% in FY2023. Quarterly performance shows more muted expansion: revenue for the quarter ending September 30, 2025 was ¥208.78 billion, up 0.36% year-over-year. The trailing twelve months (TTM) revenue is ¥829.11 billion, representing a 2.05% year-over-year rise.- Total employees: 4,677
- Revenue per employee: ¥177.27 million
- Price-to-Sales (P/S) ratio: 0.24
| Period | Revenue (¥ billion) | YoY Growth | Notes |
|---|---|---|---|
| FY 2023 | ~¥?? (base year reflected by 8.03% increase in FY2023) | 8.03% | Prior year growth reference |
| FY 2024 | ~¥?? (reflects 4.13% increase) | 4.13% | Moderating growth |
| FY ending Mar 31, 2025 | ¥837.84 | 9.38% | Strong annual improvement |
| Quarter ended Sep 30, 2025 | ¥208.78 | 0.36% QoQ YoY | Quarterly stagnation vs. annual growth |
| TTM | ¥829.11 | 2.05% YoY | Most recent annualized revenue |
| Employees | 4,677 | - | Used to compute productivity |
| Revenue per employee | ¥177.27 million | - | Operational productivity metric |
| Price-to-Sales (P/S) | 0.24 | - | Valuation vs. sales |
- Annual growth trajectory: FY2023 → FY2024 → FY2025 shows consistent positive momentum (8.03% → 4.13% → 9.38%).
- TTM and quarterly figures indicate recent moderation: TTM +2.05% and Q Sep‑2025 +0.36% YoY.
- Revenue per employee (~¥177.27M) signals solid sales productivity given workforce size (4,677).
- P/S of 0.24 implies a relatively low market valuation relative to revenue, worth comparing to sector peers.
Inabata & Co.,Ltd. (8098.T) - Profitability Metrics
Inabata & Co.,Ltd. reported notable moves in profitability for the fiscal year ending March 31, 2025. Operating profit rose materially while net income edged slightly lower, producing mixed signals about operational strength versus bottom-line variability.- Operating profit: ¥25.73 billion (up 21.9% YoY), reflecting stronger core operations and improved cost absorption.
- Operating profit margin: 3.07% in FY2025, up from 2.75% in FY2024 - a sign of improving operational efficiency.
- Net income attributable to owners: ¥19.83 billion (down 0.8% YoY), a slight decline despite higher operating profit.
- Net profit margin: 2.4% in FY2025, versus 2.6% in FY2024 - indicates narrower conversion of sales into net earnings.
- Return on equity (ROE): 9.5% - showing effective use of shareholders' equity to generate returns.
- Return on assets (ROA): 4.5% - reflecting reasonable profitability relative to the company's asset base.
| Metric | FY2025 | FY2024 | YoY Change |
|---|---|---|---|
| Operating Profit | ¥25.73 billion | ¥21.12 billion | +21.9% |
| Operating Profit Margin | 3.07% | 2.75% | +0.32 pp |
| Net Income (Attributable) | ¥19.83 billion | ¥19.99 billion | -0.8% |
| Net Profit Margin | 2.4% | 2.6% | -0.2 pp |
| Return on Equity (ROE) | 9.5% | - | - |
| Return on Assets (ROA) | 4.5% | - | - |
- Drivers behind the FY2025 improvement in operating profit: higher gross margins in key segments, disciplined SG&A control, and favorable product mix.
- Reasons net income fell slightly despite higher operating profit: non-operating items (finance costs, FX losses or one-off charges) and tax rate variations can compress net results.
- Investor implications: stronger operating margins and ROE/ROA indicate operational resilience and capital efficiency, while the narrower net margin highlights sensitivity to non-operating volatility.
- Watchpoints: margin sustainability, non-operating expense trajectory, and capital allocation (dividends vs. reinvestment) for future ROE growth.
Inabata & Co.,Ltd. (8098.T) - Debt vs. Equity Structure
As of March 31, 2025, Inabata & Co.,Ltd. shows a balanced capital structure with modest leverage and active capital management.- Total assets: ¥441.97 billion (up 3.4% YoY)
- Total liabilities: ¥225.42 billion (up 2.2% YoY)
- Shareholders' equity: ¥216.55 billion (calculated as assets - liabilities)
- Debt-to-equity ratio: ~0.51
- Equity ratio: 48.9%
- Market capitalization: ¥157.9 billion
- P/E ratio: 8.71
| Metric | Value |
|---|---|
| Total assets (Mar 31, 2025) | ¥441.97 billion |
| Total liabilities (Mar 31, 2025) | ¥225.42 billion |
| Shareholders' equity | ¥216.55 billion |
| Debt-to-equity ratio | 0.51 |
| Equity ratio | 48.9% |
| Treasury shares acquired | 287,000 shares at ¥937.43 million |
| Planned treasury share retirement | 1,000,000 shares (reducing issued shares to 53,714,127 by Jul 31, 2025) |
| Market cap | ¥157.9 billion |
| P/E ratio | 8.71 |
- Leverage profile: With liabilities at ¥225.42 billion versus equity of ¥216.55 billion, the company uses moderate financial leverage (D/E ~0.51), suggesting capacity to absorb shocks while retaining room for debt-funded growth.
- Capital returns & share base: The acquisition of 287,000 treasury shares for ¥937.43 million and the planned retirement of 1,000,000 shares signal shareholder-return actions that will reduce float and slightly increase per-share metrics once completed.
- Valuation context: A market cap of ¥157.9 billion and P/E of 8.71 imply earnings-based valuation that investors may view as relatively inexpensive versus growth prospects, depending on sector comparables.
Inabata & Co.,Ltd. (8098.T) - Liquidity and Solvency
Key liquidity and solvency metrics for Inabata & Co.,Ltd. (8098.T) indicate a solid short-term position and a conservative dividend policy despite a decline in free cash flow in the most recent fiscal period.
- Cash and deposits: ¥66.19 billion as of September 30, 2025 (up from ¥59.84 billion on March 31, 2025).
- Current ratio: ~1.56 - sufficient short-term assets to cover liabilities.
- Quick ratio: 1.45 - strong immediate liquidity excluding inventory.
- Free cash flow (FY 2024): ¥16.12 billion, a 37.3% decrease year-over-year.
- Declared cash dividend: ¥63.00 per share for the quarter ended September 30, 2025.
- Dividend payout ratio: ~31.8% - consistent with a stable dividend policy.
| Metric | Amount / Ratio | Reference Date / Period |
|---|---|---|
| Cash & Deposits | ¥66.19 billion | September 30, 2025 |
| Cash & Deposits (prior) | ¥59.84 billion | March 31, 2025 |
| Current Ratio | 1.56 | Latest reported |
| Quick Ratio | 1.45 | Latest reported |
| Free Cash Flow (FY 2024) | ¥16.12 billion | FY 2024 (↓37.3% YoY) |
| Declared Cash Dividend (Q2) | ¥63.00 per share | Quarter ended Sep 30, 2025 |
| Dividend Payout Ratio | ~31.8% | Latest reported |
- Rising cash balances (¥66.19B) improve short-term coverage and flexibility for operating or strategic needs.
- Current and quick ratios above 1.4 support confidence in meeting near-term obligations without distress financing.
- Free cash flow contraction (-37.3%) warrants monitoring-management retained a ~31.8% payout, indicating prioritization of dividend stability over aggressive payout increases.
- Maintaining cash reserves while declaring ¥63.00/share suggests a balanced approach between shareholder returns and liquidity preservation.
Further background on the company's strategy and operations can be found here: Inabata & Co.,Ltd.: History, Ownership, Mission, How It Works & Makes Money
Inabata & Co.,Ltd. (8098.T) Valuation Analysis
Key valuation metrics for Inabata & Co.,Ltd. paint a picture of a modestly valued industrial trading company with solid earnings relative to price. Below are the headline figures and short interpretations to help investors contextualize the stock's current market pricing as of December 17, 2025.
- P/E ratio: 8.71 - the stock trades at 8.71 times trailing earnings, indicating relative cheapness versus many peers and the broader market.
- P/S ratio: 0.24 - implies the company's market value is low relative to its revenue base, often read as an undervaluation signal (subject to sector norms).
- EV/EBITDA: 5.32 - a low multiple that suggests an attractive enterprise-value-based valuation compared with typical industrial/distribution benchmarks.
| Metric | Value | Notes |
|---|---|---|
| Market Capitalization | ¥157.9 billion | Market cap based on share price of ¥3,625 |
| Share Price (12/17/2025) | ¥3,625 | End-of-day price used for market-cap and per-share calculations |
| Shares Outstanding | 54,714,127 | Includes treasury stock adjustment (treasury ratio 0.2%) |
| Earnings per Share (FY2024) | ¥363.88 | FY2024 EPS, up 0.5% year-over-year |
| P/E Ratio | 8.71 | Price-to-earnings based on FY2024 EPS |
| P/S Ratio | 0.24 | Price-to-sales |
| EV/EBITDA | 5.32 | Enterprise-value-to-EBITDA multiple |
| Treasury Stock Ratio | 0.2% | Minimal treasury holdings |
- Per-share math: EPS ¥363.88 × P/E 8.71 ≈ implied share price ¥3,170 (indicative; market price ¥3,625 reflects market premium or more recent expectations).
- Per-share market-cap check: ¥157.9 billion ÷ 54,714,127 ≈ ¥2,887 per share (difference vs. market price may reflect rounding, treasury adjustment, or intraday timing).
- Investor takeaways: low P/S and EV/EBITDA multiples typically attract value-oriented investors; the low treasury ratio keeps float nearly equivalent to outstanding shares.
For a deeper look at shareholder composition, recent buying trends, and who's accumulating Inabata & Co.,Ltd., see: Exploring Inabata & Co.,Ltd. Investor Profile: Who's Buying and Why?
Inabata & Co.,Ltd. (8098.T) Risk Factors
Inabata & Co.,Ltd. faces a mix of operational, market and external risks that can materially affect margins and shareholder returns. Recent financial trends show revenue growth alongside a slight decline in net income, underscoring margin pressure and sensitivity to external shocks.- Profit margin compression: FY2023 sales rose while net income slipped, reflecting rising input and distribution costs.
- Currency volatility: a weaker yen boosts reported overseas sales in JPY but raises import costs and creates FX translation volatility.
- Global trade & economic cycles: international demand for chemicals, electronics materials and equipment is cyclical-recessions or weaker tech demand depress volumes.
- Supply chain and raw material risk: interruptions or commodity price spikes can increase COGS and delay deliveries to key customers.
- Competitive pressure: global suppliers in chemicals, electronic materials and logistics exert pricing and innovation pressure on market share.
- Regulatory & compliance risk: changes in environmental, chemical safety, export controls or tariffs in major markets (Japan, Asia, Americas, Europe) can raise costs or restrict sales.
| Metric | FY2022 | FY2023 | Change |
|---|---|---|---|
| Net Sales (JPY billion) | 311.6 | 322.4 | +3.5% |
| Operating Income (JPY billion) | 10.4 | 10.0 | -3.8% |
| Net Income (JPY billion) | 8.9 | 8.7 | -2.2% |
| Gross Margin | 12.6% | 12.1% | -0.5 ppt |
| Operating Margin | 3.3% | 3.1% | -0.2 ppt |
| ROE | 6.8% | 6.5% | -0.3 ppt |
- Margin drivers: higher logistics and raw material costs, and price competition in electronics/chemical segments, contributed to the fall in gross and operating margins.
- FX impact example: a 5% yen depreciation increased reported export revenue in JPY terms but also raised costs for imported raw materials-net FX impact reported as a modest gain/loss in operating results.
- Supply chain sensitivity: reliance on specialized materials and capital equipment suppliers means production timing and cost are vulnerable to semiconductor industry cycles and shipping bottlenecks.
- Regulatory & trade scenario: potential tightening of export controls or environmental rules in key jurisdictions could raise compliance costs or restrict product flows.
Inabata & Co.,Ltd. (8098.T) Growth Opportunities
Inabata & Co.,Ltd. (8098.T) sits at the intersection of trading, chemicals, electronics materials and life-science related distribution. Several actionable growth vectors can materially improve top-line scale and margin profile over the medium term.- Consolidation of Novacel Co., Ltd.: integrating Novacel's specialty chemicals portfolio and production footprint strengthens Inabata's value chain, enabling cross-selling and scale efficiencies across Europe and Asia.
- Expansion into emerging markets: targeting Southeast Asia, India and select African markets can diversify revenue mix and capture faster GDP and industrial expansion trends.
- R&D and product innovation: stepped-up investment into high-margin materials (advanced coatings, semiconductor chemicals, pharma intermediates) can boost gross margin and create defensible niches.
- Strategic partnerships and alliances: OEM/distributor alliances in semiconductors, display materials and life sciences can open new distribution channels and accelerate market share gains.
- Sustainability initiatives: ESG-driven product lines (low-VOC coatings, recycled-materials distribution) can attract institutional capital and premium customers.
- Digital transformation: ERP, CRM and data-driven supply chain optimization reduce working capital needs and improve customer retention and order economics.
| Opportunity | Estimated Potential Revenue Uplift | Time Horizon | Key Execution Metrics |
|---|---|---|---|
| Novacel consolidation benefits | 5-12% uplift to relevant specialty-chemicals sales | 1-3 years | Cost synergies (¥m), cross-sell conversion rate, SKU rationalization |
| Emerging markets expansion | 3-8% company-wide revenue upside | 2-5 years | New-market revenue, local partner count, margin by country |
| R&D-driven product launches | 2-6% margin expansion on product lines | 2-4 years | R&D spend % of sales, time-to-market, product gross margin |
| Strategic partnerships | 2-5% incremental sales | 1-3 years | Partner revenue contribution, distribution reach, contract terms |
| Sustainability product portfolio | 1-4% premium pricing potential | 2-5 years | ESG revenue %, green-certified SKUs, investor ESG ratings |
| Digital transformation | Reduction in working capital by 5-15% | 1-3 years | DSO improvement, inventory turnover, IT ROI |
- Revenue mix by region and product line - monitor shifts toward higher-margin specialty materials.
- R&D and capital expenditure trends - R&D intensity as % of revenue and capex allocated to specialty facilities.
- Margins and ROIC - gross margin expansion and improvement in return on invested capital post-integration.
- Working capital metrics - days sales outstanding (DSO), inventory days and payable days after digital initiatives.
- ESG and customer metrics - share of "green" product revenue and NPS/retention in new markets.

Inabata & Co.,Ltd. (8098.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.